ABCD3

protein-coding

ATP binding cassette subfamily D member 3, the group of ATP binding cassette subfamily D|GOLD domain containing

Gene summary

The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein likely plays an important role in peroxisome biogenesis. Mutations have been associated with some forms of Zellweger syndrome, a heterogeneous group of peroxisome assembly disorders. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]

Previous symbols:
  • PXMP1

MANE transcript

NM_002858.4

Inheritance

AR

ClinVar variants

P:1U:124B:44

Top phenotype

Bile acid synthesis defect, congenital, 5

gnomAD constraint

pLI —, LoF o/e 0.28

Max pathogenic AF

—

Genomic locus

chr1:94,418,389-94,518,666

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~100.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

congenital bile acid synthesis defect 5MODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0014564

Submitter: PanelApp Australia

congenital bile acid synthesis defect 5LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014564

Submitter: Ambry Genetics

congenital bile acid synthesis defect 5LIMITED

Inheritance Pattern: Unknown

Disease ID:MONDO:0014564

Submitter: Labcorp Genetics (formerly Invitae)

congenital bile acid synthesis defect 5LIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0014564

Submitter: ClinGen

The relationship between *ABCD3* and congenital bile acid synthesis defect 5 (ABCD3 congenital bile acid synthesis defect), an autosomal recessive disorder, was evaluated using the ClinGen Clinical Validity Framework as of April, 2022. *ABCD3* encodes an ATP-binding cassette transporter involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs (also called peroxisomal membrane protein 70, PMP70). Some of the phenotypes associated with ABCD3 congenital bile acid synthesis defect or include hepatomegaly, jaundice and increased plasma bile acid intermediates and VLCFAs. *ABCD3* was first reported in relation to autosomal recessive congenital bile acid synthesis defect in 2015. (Ferdinandusse et al, PMID: 25168382). This is the only report of a genetic defect in *ABCD3* identified in a human patient. Earlier, *ABCD3* was associated with peroxisome biogenesis as mutations were identified in the *ABCD3* gene in patients with Zellweger syndrome. However, it was later shown that a *PEX1* defect was the underlying cause of peroxisome biogenesis disorder in those patients (PMID: 25168382). Summary of Case Level Data (1 point): A homozygous deletion variant has been reported in 1 proband in 1 publication (PMID: 25168382), wherein a truncated protein product is shown to be made. The mechanism for disease is expected to be homozygous loss of function. Summary of experimental data (4 points): This gene-disease association is supported by a mouse models that recapitulate some of the human disease phenotype (PMIDs 25168382, 34564857) and protein interactions with *ABCD1* (PMID: 10551832) and PEX19 (PMID: 16344115). In summary, there is limited evidence to support the gene-disease relationship of *ABCD3* and congenital bile acid synthesis defect 5. While more evidence is needed to establish this relationship definitively, no convincing contradictory evidence has emerged. This gene-disease pair was originally evaluated by the Peroxisomal GCEP on April 27, 2022. It was reevaluated on June 6, 2025 (SOP v 10). No new evidence was added and the classification did not change.

Clinical Genomic Database (CGD)

Bile acid synthesis defect, congenital, 5AR

Manifestation: Biochemical; Craniofacial; Gastrointestinal; Neurologic

Intervention: Gastrointestinal

Rationale: Early interventions, such as with bile replacement therapy, may be beneficial, though liver transplant may be necessary

Refs: 1301993; 9199576; 10447258; 17092750; 25168382Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to ABCD3 variants in ClinVar

4 Conditions Cataloged
not providedTotal: 150
not specifiedTotal: 82
ABCD3-related disorderTotal: 26
Congenital bile acid synthesis defect 5Total: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_002858.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
39
clinvar
2
clinvar
42
missense
111
clinvar
2
clinvar
1
clinvar
114
nonsense
4
clinvar
4
start loss
0
frameshift
2
clinvar
2
splice donor/acceptor (+/-2bp)
1
clinvar
6
clinvar
7
Total10124413169
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 72 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_002858.4RefSeqNP_002849.123MANE Select
ENST00000370214.9EnsemblENSP00000359233.423MANE Select
NM_001122674.2RefSeqNP_001116146.19Standard
ENST00000315713.5EnsemblENSP00000326880.59Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Peroxisome - Homo sapiens (human)
  • ABC transporters - Homo sapiens (human)
  • Nuclear Receptors in Lipid Metabolism and Toxicity
  • ABC transporters in lipid homeostasis
  • Transport of small molecules

Biological Process

  • fatty acid biosynthetic process
  • fatty acid beta-oxidation
  • peroxisome organization
  • response to organic cyclic compound
  • peroxisomal long-chain fatty acid import

Molecular Function

  • long-chain fatty acid transporter activity
  • protein binding
  • ATP binding
  • ATPase activity
  • ATPase activity, coupled to transmembrane movement of substances

Cellular Component

  • mitochondrion
  • peroxisome
  • peroxisomal membrane
  • peroxisomal matrix
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000370214
Coding exons
23
Length
100290
Individuals with no LoFs
125707
Homozygous LoFs
0
Heterozygous LoFs
32
Defined
125739
p
0.000127
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.542293660.6260.00001954292
Missense (PolyPhen)53139.320.380411560
Synonymous0.8211111230.9060.000006111233
Loss of Function4.751450.30.2780.00000312541

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000640.000062rare
Latino/Admixed American0.0000870.000087rare
Ashkenazi Jewish0.000600.00060rare
East Asian00.0absent
Finnish0.0000460.000046rare
European (Non-Finnish)0.000130.00013rare
South Asian0.000140.00013rare
Other0.000330.00033rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Probable transporter involved in the transport of branched-chain fatty acids and C27 bile acids into the peroxisome; the latter function is a crucial step in bile acid biosynthesis (PubMed:25168382). The nucleotide-binding fold acts as an ATP- binding subunit with ATPase activity (PubMed:11248239). {ECO:0000269|PubMed:11248239, ECO:0000269|PubMed:25168382}.;
Disease
DISEASE: Congenital bile acid synthesis defect 5 (CBAS5) [MIM:616278]: An autosomal recessive disorder characterized by hepatosplenomegaly, hepatic fibrosis, progressive liver failure, and accumulation of peroxisomal C27-bile acid intermediates in plasma. {ECO:0000269|PubMed:25168382}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.297

Intolerance Scores

LoFtool
0.115
RVIS EVS
-0.65
RVIS percentile EVS
16.44

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.806

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.